Cours InVitro International Other OTC
Actions
IVRO
US4618531036
Produits pharmaceutiques
CA 2022 | 854 k 776 k | CA 2023 | 793 k 720 k | Capitalisation | 1,3 M 1,18 M |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | - 0 | VE / CA 2022 | 0,29 x |
Trésorerie nette 2022 | 1,23 M 1,12 M | Trésorerie nette 2023 | 1,13 M 1,03 M | VE / CA 2023 | 0,22 x |
PER 2022 |
69,3
x | PER 2023 |
885
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 96,73% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
W. Ulmer
CEO | Chief Executive Officer | - | 15/09/19 |
Cathy Richmond
DFI | Director of Finance/CFO | - | 15/09/19 |
Atul Jhalani
PSD | President | - | 03/06/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Irwin Gruverman
BRD | Director/Board Member | 89 | 23/09/20 |
Dennis Chenoweth
BRD | Director/Board Member | - | - |
W. Ulmer
CEO | Chief Executive Officer | - | 15/09/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,98% | 682 Md | |
+30,34% | 586 Md | |
-3,52% | 364 Md | |
+18,59% | 327 Md | |
+4,07% | 285 Md | |
+16,21% | 240 Md | |
+9,66% | 209 Md | |
-6,83% | 203 Md | |
+7,09% | 165 Md |